Baxter to Present at the 30th Annual J.P. Morgan
Health Care Conference
December 21, 2011 09:18 AM Eastern Time
DEERFIELD, Ill.--(EON: Enhanced Online News)--Baxter International Inc. (NYSE: BAX) announced today that
it will present at the 30th Annual J.P. Morgan Health Care Conference on Tuesday, January 10, 2012, at 2:30 p.m.
(PT) or 5:30 p.m. (ET).
The live webcast of Baxter’s presentation can be accessed from the Baxter corporate website at www.baxter.com
and will be available for replay through February 9, 2012.
Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with
hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical
conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical
devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.
Baxter International Inc.
Deborah Spak, (847) 948-2349
Mary Kay Ladone, (847) 948-3371
Clare Trachtman, (847) 948-3085
Recent Stories from Baxter International Inc.
FDA Approves Baxter’s ADVATE as the Only FVIII for Routine Prophylaxis in Both Adults and Children
With Hemophilia A
December 16, 2011
DEERFIELD, Ill.--(EON: Enhanced Online News)--Baxter today announced that the FDA has approved
ADVATE for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients wit...
Baxter Responds to Patient Needs in Aftermath of Thailand Floods
December 15, 2011
DEERFIELD, Ill.--(EON: Enhanced Online News)--Baxter International Inc. (NYSE: BAX) demonstrated
its commitment to volunteerism and product donation as well as to environmentally-conscious practice... more
Baxter Signs Definitive Agreement to Acquire Synovis
December 13, 2011
DEERFIELD, Ill. & ST. PAUL, Minn.--(EON: Enhanced Online News)--Baxter International Inc.
(NYSE:BAX) and Synovis Life Technologies, Inc. (NASDAQ:SYNO) today announced a definitive
agreement for Bax... more »